210 related articles for article (PubMed ID: 37019424)
21. Current and future treatments for Behçet's uveitis: road to remission.
Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Dick AD; Adán A
Int Ophthalmol; 2014 Apr; 34(2):365-81. PubMed ID: 23729309
[TBL] [Abstract][Full Text] [Related]
22. Behçet's disease: ocular effects and treatment.
Deuter CM; Kötter I; Wallace GR; Murray PI; Stübiger N; Zierhut M
Prog Retin Eye Res; 2008 Jan; 27(1):111-36. PubMed ID: 18035584
[TBL] [Abstract][Full Text] [Related]
23. Behçet's disease--a contemporary review.
Mendes D; Correia M; Barbedo M; Vaio T; Mota M; Gonçalves O; Valente J
J Autoimmun; 2009; 32(3-4):178-88. PubMed ID: 19324519
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of diagnostic performance of haematological parameters in Behçet's disease.
Tezcan D; Körez MK; Gülcemal S; Hakbilen S; Akdağ T; Yılmaz S
Int J Clin Pract; 2021 Oct; 75(10):e14638. PubMed ID: 34309974
[TBL] [Abstract][Full Text] [Related]
25. [Behçet's disease from the aspect of autoinflammatory disease].
Ishigatsubo Y; Samukawa S
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):408-19. PubMed ID: 22041429
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of Behcet's disease in Mongolia: a multicenter study.
Balt J; Jamyanjav B; Jav S; Dandii Z; Ganbold C; Horie Y; Lennikov A; Uehara O; Ohno S; Kitaichi N
Clin Rheumatol; 2020 Sep; 39(9):2697-2706. PubMed ID: 32157471
[TBL] [Abstract][Full Text] [Related]
27. Advances in pathogenesis and treatment of ocular involvement in Behcet's disease.
Lin S; Xu Z; Lin Z; Xie B; Feng J
Front Immunol; 2023; 14():1206959. PubMed ID: 37841268
[TBL] [Abstract][Full Text] [Related]
28. Immunopathogenesis of Behcet's Disease.
Tong B; Liu X; Xiao J; Su G
Front Immunol; 2019; 10():665. PubMed ID: 30984205
[TBL] [Abstract][Full Text] [Related]
29. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?
Hammad M; Shehata OZ; Abdel-Latif SM; El-Din AMM
Clin Rheumatol; 2018 Oct; 37(10):2811-2817. PubMed ID: 29980877
[TBL] [Abstract][Full Text] [Related]
30. Chemokines and chemokine receptors in Behçet's disease.
Li Z; Cheng L; Zhan H; Li Y
Front Immunol; 2023; 14():1109147. PubMed ID: 36742301
[TBL] [Abstract][Full Text] [Related]
31. The clinical feature of Behçet's disease in Northeastern China.
Shang Y; Han S; Li J; Ren Q; Song F; Chen H
Yonsei Med J; 2009 Oct; 50(5):630-6. PubMed ID: 19881965
[TBL] [Abstract][Full Text] [Related]
32. Biotherapies in Behçet's disease.
Comarmond C; Wechsler B; Bodaghi B; Cacoub P; Saadoun D
Autoimmun Rev; 2014 Jul; 13(7):762-9. PubMed ID: 24473176
[TBL] [Abstract][Full Text] [Related]
33. Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behçet's disease.
Perazzio SF; Soeiro-Pereira PV; Dos Santos VC; de Brito MV; Salu B; Oliva MLV; Stevens AM; de Souza AWS; Ochs HD; Torgerson TR; Condino-Neto A; Andrade LEC
Arthritis Res Ther; 2017 Oct; 19(1):235. PubMed ID: 29052524
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of Behçet's disease].
Comarmond C; Wechsler B; Cacoub P; Saadoun D
Rev Med Interne; 2014 Feb; 35(2):126-38. PubMed ID: 24438860
[TBL] [Abstract][Full Text] [Related]
35. Behçet's disease: An immunogenetic perspective.
Salmaninejad A; Zamani MR; Shabgah AG; Hosseini S; Mollaei F; Hosseini N; Sahebkar A
J Cell Physiol; 2019 Jun; 234(6):8055-8074. PubMed ID: 30341905
[TBL] [Abstract][Full Text] [Related]
36. The roles of immune cells in Behçet's disease.
Hu D; Guan JL
Adv Rheumatol; 2023 Oct; 63(1):49. PubMed ID: 37814339
[TBL] [Abstract][Full Text] [Related]
37. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional analysis of neutrophils from patients with Behçet's disease reveals activation and chemotaxis of neutrophils.
Yu X; Li L; Zhang M; Liu J; Chen H; Zhang F; Zheng W
Clin Immunol; 2022 Dec; 245():109161. PubMed ID: 36243348
[TBL] [Abstract][Full Text] [Related]
39. Mucocutaneous manifestations of Behçet's disease: Pathogenesis and management from perspectives of vasculitis.
Kim D; Nakamura K; Kaneko F; Alpsoy E; Bang D
Front Med (Lausanne); 2022; 9():987393. PubMed ID: 36530905
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease.
Balkarli A; Kucuk A; Babur H; Erbasan F
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3045-50. PubMed ID: 27460734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
